A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19)
Phase 4
- Conditions
- novel coronavirus pneumonia (COVID-19)
- Registration Number
- ITMCTR2000002954
- Lead Sponsor
- Beijing hospital of Traditional Chinese medicine; Hubei integrated traditional Chinese and Western Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1) Pneumonia patients diagnosed as new coronavirus infection;
2) The type of pneumonia was judged as severe and critical;
3) Informed consent.
Exclusion Criteria
1) patients were judged not suitable to participate in the study;
2) patients were not suitable to use Chinese patent medicine.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mechanical ventilation time;Length of stay in hospital;PSI score;CURB-65;
- Secondary Outcome Measures
Name Time Method Antipyretic time;Time of virus turning negative;Pulmonary function;mortality and recovery rate;Adverse events;rate of multiple organ dysfunction;Inflammation index;